What proportion of patients with stage I NSCLC seen in the oncology clinic are treated with SABR?. (January 2020) - Brennan, E.; Garbett, A.; Hoey, P.; Cobben, D.; Chan, C.; Coote, J.; Faivre-Finn, C.; Harris, M.; Hudson, A.; Pemberton, L.; Salem, A.; Sheikh, H.; et al.